BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28991855)

  • 1. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
    Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
    Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracolonic Cancer Risk After Total Colectomy for Inflammatory Bowel Disease: A Population-based Cohort Study.
    Mark-Christensen A; Erichsen R; Veres K; Laurberg S; Sørensen HT
    J Crohns Colitis; 2020 Jun; 14(5):630-635. PubMed ID: 31811282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    Taborelli M; Sozzi M; Del Zotto S; Toffolutti F; Montico M; Zanier L; Serraino D
    PLoS One; 2020; 15(6):e0235142. PubMed ID: 32574216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.
    van den Heuvel TR; Wintjens DS; Jeuring SF; Wassink MH; Romberg-Camps MJ; Oostenbrug LE; Sanduleanu S; Hameeteman WH; Zeegers MP; Masclee AA; Jonkers DM; Pierik MJ
    Int J Cancer; 2016 Sep; 139(6):1270-80. PubMed ID: 27170593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
    Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
    J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ
    Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
    Zhang H; Zhang M; Chen X; Guo M; Zhou R; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
    Int J Cancer; 2022 Jun; 150(11):1770-1778. PubMed ID: 35037241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
    Ko MK; Ng SC; Mak LY; Li MK; Lo FH; Ng CK; Lao WC; Tsang S; Chan KH; Hui YT; Shan EH; Loo CK; Hui AJ; To WP; Hung IF; Leung WK
    J Dig Dis; 2016 Sep; 17(9):610-617. PubMed ID: 27533786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.
    Pedersen N; Duricova D; Elkjaer M; Gamborg M; Munkholm P; Jess T
    Am J Gastroenterol; 2010 Jul; 105(7):1480-7. PubMed ID: 20332773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
    Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
    Gut; 2005 May; 54(5):617-22. PubMed ID: 15831904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.
    Jussila A; Virta LJ; Pukkala E; Färkkilä MA
    Scand J Gastroenterol; 2013 Dec; 48(12):1405-13. PubMed ID: 24131389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.